Burning Rock Biotech filed its 2025 Annual Report with the SEC, available for shareholders upon request.
Quiver AI Summary
Burning Rock Biotech Limited announced the filing of its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission on April 28, 2026. The report is accessible on both the SEC website and the Company’s investor relations site. Shareholders and ADS holders can request a hard copy of the report, which includes audited financial statements, free of charge. Burning Rock focuses on utilizing next generation sequencing technology in precision oncology, specifically for therapy selection in late-stage cancer patients and cancer early detection. The release also includes a safe harbor statement regarding forward-looking statements, emphasizing the uncertainties and risks associated with the company's future expectations and plans.
Potential Positives
- Burning Rock Biotech has successfully filed its Annual Report on Form 20-F, a vital regulatory requirement that enhances corporate transparency and governance.
- The company offers free access to its audited consolidated financial statements to shareholders and ADS holders, demonstrating a commitment to transparency and shareholder engagement.
- The press release highlights the company's focus on precision oncology, showcasing its role in next-generation sequencing technology, which is a highly relevant and growing field in healthcare.
Potential Negatives
- None
FAQ
What is Burning Rock Biotech Limited?
Burning Rock Biotech Limited is a company specializing in next generation sequencing technology for precision oncology applications.
When did Burning Rock file its Annual Report on Form 20-F?
Burning Rock filed its Annual Report on Form 20-F on April 28, 2026, for the year ended December 31, 2025.
Where can I view the Form 20-F?
The Form 20-F is available on the SEC website at www.sec.gov and on Burning Rock's website at http://ir.brbiotech.com.
How can shareholders request a hard copy of the Form 20-F?
Shareholders can request a hard copy by contacting Burning Rock at their office address or via email at [email protected].
What services does Burning Rock offer in oncology?
Burning Rock offers NGS-based therapy selection testing and cancer early detection services in precision oncology.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BNR Insider Trading Activity
$BNR insiders have traded $BNR stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BNR stock by insiders over the last 6 months:
- YUSHENG HAN purchased 314,870 shares for an estimated $5,466,143
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$BNR Hedge Fund Activity
We have seen 5 institutional investors add shares of $BNR stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CRCM LP added 269,851 shares (+121.8%) to their portfolio in Q4 2025, for an estimated $5,437,497
- PROSPERA FINANCIAL SERVICES INC removed 31,185 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $503,014
- MARSHALL WACE, LLP added 10,903 shares (+inf%) to their portfolio in Q4 2025, for an estimated $219,695
- MORGAN STANLEY removed 10,427 shares (-46.8%) from their portfolio in Q4 2025, for an estimated $210,104
- SKYVIEW INVESTMENT ADVISORS, LLC removed 10,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $201,500
- SUMITOMO MITSUI TRUST GROUP, INC. removed 3,035 shares (-8.7%) from their portfolio in Q4 2025, for an estimated $61,155
- AMOVA ASSET MANAGEMENT AMERICAS, INC. removed 3,035 shares (-8.7%) from their portfolio in Q4 2025, for an estimated $61,155
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Full Release
GUANGZHOU, China, April 28, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing technology in the field of precision oncology, announces that on April 28, 2026 it filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (“SEC”). The Form 20-F is available for viewing on the SEC website at www.sec.gov and also on the Company’s website at http://ir.brbiotech.com. The Company will provide a hard copy of the Form 20-F containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to Burning Rock Biotech Limited, No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, or via email at [email protected].
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
For more information about Burning Rock, please visit: http://ir.brbiotech.com
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “confident” and similar statements. Burning Rock may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Burning Rock’s beliefs and expectations, are forward-looking statements. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rock’s control. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. All information provided in this press release is as of the date of this press release, and Burning Rock does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
Contact: [email protected]